Verastem Oncology provides update on Ramp 203 phase 1/2 clinical trial
Verastem Oncology provides update on Ramp 203 phase 1/2 clinical trial
2 months ago
marketscreener.com
Pipeline | Verastem, Inc.
Pipeline | Verastem, Inc.
3 weeks ago
verastem.com
Verastem Oncology Selects Oral Kras G12d Inhibitor Gfh375/Vs-7375 as Lead Program in Discovery and Development Collaboration with Genfleet Therapeutics
Verastem Oncology Selects Oral Kras G12d Inhibitor Gfh375/Vs-737…
Dec 18, 2023
marketscreener.com
Verastem Oncology publie de nouvelles données positives sur l'étude de phase 1/2 de GenFleet Therapeutics en Chine pour le GFH375 (VS-7375) dans l'adénocarcinome canalaire pancréatique mutant KRAS G12D
Verastem Oncology publie de nouvelles données positives sur l'…
4 months ago
zonebourse.com
Verastem Oncology : Données préliminaires prometteuses pour l'inhibiteur oral VS-7375 ciblant la mutation KRAS G12D
Verastem Oncology : Données préliminaires prometteuses pour l'…
4 months ago
zonebourse.com
Research | Verastem, Inc.
Research | Verastem, Inc.
11 months ago
verastem.com
Verastem Oncology and STAAR Ovarian Cancer Foundation Establish the Inaugural Low-Grade Serous Ovarian Cancer (LGSOC) Awareness Day on September 9, 2024
Verastem Oncology and STAAR Ovarian Cancer Foundation Establ…
Sep 3, 2024
financialpost.com
1:34
Exclusive Interview with Dr. Jonathan Pachter, Chief Scientific …
67 views7 months ago
YouTubeGeneOnline 基因線上
14:51
FDA Approves the AVMAPKI™ FAKZYNJA™ Combination Therap…
9 months ago
YahooBusiness Wire
0:11
The World Ovarian Cancer Coalition is grateful to partners like Veraste…
41 views3 weeks ago
FacebookWorld Ovarian Cancer Coalition
Vstm Stock Quote: Verastem's Rise in Cancer-Focused Trading
5 months ago
cgaa.org
1:58
How the Veradigm Network Transforms Healthcare with Real-…
826 viewsAug 21, 2024
YouTubeVeradigm®
2:04
FDA Approves First Gene Therapy To Successfully Treat Cancer | NB…
28.1K viewsJul 12, 2017
YouTubeNBC News
13:02
VSTM Verastem Oncology: After RAMP 203 Halt - 5 Stock Price Sce…
25 views2 months ago
YouTubeStockInvest.us
Hedge Funds Never Loved Verastem Inc (VSTM) More
Jun 24, 2020
insidermonkey.com
Verastem (NASDAQ:VSTM) shareholders have endured a 62% …
Aug 12, 2022
nasdaq.com
35:02
Inside Cancer Innovation Radiopharm ASX RAD Shares Wh…
186 views5 months ago
YouTubeKalkine Media
24:58
Know Your Company | AstraZeneca: Leading Revolution In Oncology | …
1.5K viewsDec 2, 2024
YouTubeNDTV Profit
6:10
Ras Raf MEK ERK Signaling Pathway - Overview, Regulation a…
1.9K viewsNov 30, 2019
bilibilitggtgg
1:36
Efficiency Meets Care: Transforming Healthcare with Veradigm
53.6K viewsNov 22, 2023
YouTubeVeradigm®
4:06
Veradigm | All in one EHR | Software Review by Software Finder
4.6K viewsAug 17, 2023
YouTubeSoftware Finder
7:49
AVMAPKI FAKZYNJA CO-PACK - FDA NDA approval - 2025-05-08
186 views9 months ago
YouTubeInside Drug Discovery
1:38:34
KRAS Cancer Clinical Trial Updates: What Patients Need to Know from …
27.9K views8 months ago
YouTubeKRAS Cancer Kickers
VSTM
Mar 1, 2012
zacks.com
VERITAC-2: a Phase III study of vepdegestrant, a PROTAC ER deg…
Jun 27, 2024
nih.gov
2:40
What is VeriSM? - a basic and (fun) active introduction
1.3K viewsJun 6, 2018
YouTubeVan Haren Group (www.vanharen.net)
4:25
Verastem MOA Video
70 viewsSep 18, 2023
VimeoVerastem
Beresford Discusses Using VeriStrat With Immunotherapies
May 12, 2015
onclive.com
Verastem Oncology | LinkedIn
Jan 1, 2009
linkedin.com
1:48
FAK Inhibitors Market Outlook | Emerging Cancer Therapies, Mark…
3 views1 month ago
YouTubeDelveInsight Business Research
See more videos
Static thumbnail place holder